Abeona Therapeutics Inc. (ABEO) vs CapsoVision, Inc. (CV)
A side-by-side comparison of Abeona Therapeutics Inc. and CapsoVision, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABEO
Abeona Therapeutics Inc.
$4.97HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT
CV
CapsoVision, Inc.
$6.40HealthcareDelayed quote: Oct 6, 2026, 10:22 AM EDT
Total return — ABEO vs CV
growth of $100 · dividends reinvested · last 1yABEO -14.6% (-14.6%/yr)CV +88.3% (+88.3%/yr)CV compounded faster over this window
ABEO CV
ABEO vs CV: by the numbers
- •CV is the larger company ($320M vs $283M market cap).
- •Both run net losses; CV's is the smaller (-214.74% vs -246.42% net margin).
Metrics side by side
Valuation
| Metric | ABEO | CV |
|---|---|---|
| P/S ratio | 11.09 | 23.02 |
| P/B ratio | 2.21 | 24.29 |
Profitability
| Metric | ABEO | CV |
|---|---|---|
| Gross margin | 73.68% | 50.88% |
| Operating margin | -1536.91% | -188.25% |
| Net margin | -246.42% | -214.74% |
| ROE | -49.11% | -226.56% |
| ROIC | -49.76% | -164.32% |
Growth (annualized)
| Metric | ABEO | CV |
|---|---|---|
| Revenue CAGR (5Y) | -10.26% | N/A |
| Total return CAGR (5Y) | -26.46% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.